325 related articles for article (PubMed ID: 32661108)
1. Effect of Afrezza on Glucose Dynamics During HCL Treatment.
Galderisi A; Cohen N; Calhoun P; Kraemer K; Breton M; Weinzimer S; Cengiz E
Diabetes Care; 2020 Sep; 43(9):2146-2152. PubMed ID: 32661108
[TBL] [Abstract][Full Text] [Related]
2. Comparison between preprandial vs. postprandial insulin aspart in patients with type 1 diabetes on insulin pump and real-time continuous glucose monitoring.
Thuillier P; Sonnet E; Alavi Z; Roudaut N; Nowak E; Dion A; Kerlan V
Diabetes Metab Res Rev; 2018 Sep; 34(6):e3019. PubMed ID: 29749032
[TBL] [Abstract][Full Text] [Related]
3. Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
Bode BW; Johnson JA; Hyveled L; Tamer SC; Demissie M
Diabetes Technol Ther; 2017 Jan; 19(1):25-33. PubMed ID: 28055230
[TBL] [Abstract][Full Text] [Related]
4. Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover Study.
Riddle MC; Nahra R; Han J; Castle J; Hanavan K; Hompesch M; Huffman D; Strange P; Öhman P
Diabetes Care; 2018 Nov; 41(11):2346-2352. PubMed ID: 30213882
[TBL] [Abstract][Full Text] [Related]
5. Optimizing postprandial glycemia in pediatric patients with type 1 diabetes using insulin pump therapy: impact of glycemic index and prandial bolus type.
O'Connell MA; Gilbertson HR; Donath SM; Cameron FJ
Diabetes Care; 2008 Aug; 31(8):1491-5. PubMed ID: 18509207
[TBL] [Abstract][Full Text] [Related]
6. Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes.
Pettis RJ; Hirsch L; Kapitza C; Nosek L; Hövelmann U; Kurth HJ; Sutter DE; Harvey NG; Heinemann L
Diabetes Technol Ther; 2011 Apr; 13(4):443-50. PubMed ID: 21355716
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of Postprandial Glucose Control in the Medtronic Advanced Hybrid Closed-Loop System Versus 670G.
Weinzimer SA; Bailey RJ; Bergenstal RM; Nimri R; Beck RW; Schatz D; Ambler-Osborn L; Schweiger DS; von dem Berge T; Sibayan J; Johnson ML; Calhoun P; Phillip M;
Diabetes Technol Ther; 2022 Aug; 24(8):573-582. PubMed ID: 35363054
[No Abstract] [Full Text] [Related]
8. The additional dose of insulin for high-protein mixed meal provides better glycemic control in children with type 1 diabetes on insulin pumps: randomized cross-over study.
Piechowiak K; Dżygało K; Szypowska A
Pediatr Diabetes; 2017 Dec; 18(8):861-868. PubMed ID: 28117542
[TBL] [Abstract][Full Text] [Related]
9. Improved postprandial glycemic control in patients with type 2 diabetes from subcutaneous injection of insulin lispro with hyaluronidase.
Hompesch M; Muchmore DB; Morrow L; Ludington E; Vaughn DE
Diabetes Technol Ther; 2012 Mar; 14(3):218-24. PubMed ID: 22136324
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and postprandial glycemic excursions following insulin lispro delivered by intradermal microneedle or subcutaneous infusion.
McVey E; Hirsch L; Sutter DE; Kapitza C; Dellweg S; Clair J; Rebrin K; Judge K; Pettis RJ
J Diabetes Sci Technol; 2012 Jul; 6(4):743-54. PubMed ID: 22920798
[TBL] [Abstract][Full Text] [Related]
11. Insulin delivery patterns required to maintain postprandial euglycemia in type 1 diabetes following consumption of traditional Egyptian Ramadan Iftar meal using insulin pump therapy: A randomized crossover trial.
Elbarbary NS; Elhenawy YI; Ali ARR; Smart CE
Pediatr Diabetes; 2022 Dec; 23(8):1628-1634. PubMed ID: 36285573
[TBL] [Abstract][Full Text] [Related]
12. Effect of insulin feedback on closed-loop glucose control: a crossover study.
Ruiz JL; Sherr JL; Cengiz E; Carria L; Roy A; Voskanyan G; Tamborlane WV; Weinzimer SA
J Diabetes Sci Technol; 2012 Sep; 6(5):1123-30. PubMed ID: 23063039
[TBL] [Abstract][Full Text] [Related]
13. The Use of a Smart Bolus Calculator Informed by Real-time Insulin Sensitivity Assessments Reduces Postprandial Hypoglycemia Following an Aerobic Exercise Session in Individuals With Type 1 Diabetes.
Fabris C; Nass RM; Pinnata J; Carr KA; Koravi CLK; Barnett CL; Oliveri MC; Anderson SM; Chernavvsky DR; Breton MD
Diabetes Care; 2020 Apr; 43(4):799-805. PubMed ID: 32144167
[TBL] [Abstract][Full Text] [Related]
14. Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.
Chase HP; Doyle FJ; Zisser H; Renard E; Nimri R; Cobelli C; Buckingham BA; Maahs DM; Anderson S; Magni L; Lum J; Calhoun P; Kollman C; Beck RW;
Diabetes Technol Ther; 2014 Oct; 16(10):623-32. PubMed ID: 25188375
[TBL] [Abstract][Full Text] [Related]
15. Improved Postprandial Glucose Control Using the InsuPad Device in Insulin-Treated Type 2 Diabetes: Injection Site Warming to Improve Glycemic Control.
Raz I; Bitton G; Feldman D; Alon T; Pfutzner A; Tamborlane WV
J Diabetes Sci Technol; 2015 May; 9(3):639-43. PubMed ID: 25883166
[TBL] [Abstract][Full Text] [Related]
16. Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial.
Dovc K; Piona C; Yeşiltepe Mutlu G; Bratina N; Jenko Bizjan B; Lepej D; Nimri R; Atlas E; Muller I; Kordonouri O; Biester T; Danne T; Phillip M; Battelino T
Diabetes Care; 2020 Jan; 43(1):29-36. PubMed ID: 31575640
[TBL] [Abstract][Full Text] [Related]
17. Rate of Change of Premeal Glucose Measured by Continuous Glucose Monitoring Predicts Postmeal Glycemic Excursions in Patients With Type 1 Diabetes: Implications for Therapy.
Majithia AR; Wiltschko AB; Zheng H; Walford GA; Nathan DM
J Diabetes Sci Technol; 2018 Jan; 12(1):76-82. PubMed ID: 28868899
[TBL] [Abstract][Full Text] [Related]
18. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
[TBL] [Abstract][Full Text] [Related]
19. Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program.
Danne T; Cariou B; Buse JB; Garg SK; Rosenstock J; Banks P; Kushner JA; McGuire DK; Peters AL; Sawhney S; Strumph P
Diabetes Care; 2019 May; 42(5):919-930. PubMed ID: 30833371
[TBL] [Abstract][Full Text] [Related]
20. Assessment of optimal insulin administration timing for standard carbohydrates-rich meals using continuous glucose monitoring in children with type 1 diabetes: A cross-over randomized study.
Tucholski K; Sokołowska M; Tucholska D; Kamińska H; Jarosz-Chobot P
J Diabetes Investig; 2019 Sep; 10(5):1237-1245. PubMed ID: 30768859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
